External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience MDA 2026
Roche and Genentech at

MDA 2026

March 08 - March 11
Orlando, USA / Virtual (Hybrid)
mdaconference.org
We will be contributing to topics related to
Neuroscience
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
10:00 PM
Duration 120mins Orlando, USA
RAINBOWFISH: 3-year efficacy and safety data of risdiplam in children with presymptomatic (SMA)
Laurent Servais
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
5-year safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA)
Carol Jean Guittari
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
The comparative efficacy and safety of risdiplam versus high-dose nusinersen in children with Type 1 spinal muscular atrophy (SMA)
Julian Nam
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
Caregiver Global Impressions of Delandistrogene Moxeparvovec in Participants with Duchenne Muscular Dystrophy: Findings from EMBARK 2-year Follow-up
Teofil Ciobanu
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
Pooled Safety Analysis from Phase 1 to Phase 3 Clinical Trials of Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy
Craig M. McDonald
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Functional and Safety Outcomes up to 3 Years Post-Infusion in the EMBARK Study
Craig M. McDonald
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:00 PM
Duration 120mins Orlando, USA
Fertility in Risdiplam-Treated Adult Males with Spinal Muscular Atrophy (SMA): the MARLIN study
Sheila Shapouri, Sheila Seleri, Natan Bar-Chama, Shafeeq Ladha, Shereen Yap, Elise Lim, Rushabh Shah, Travis Dickendesher
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 PM
Duration 15mins Hilton Orlando, Orlando, FL, Room Name: Florida 4
Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Functional and Safety Outcomes up to 3 Years Post-Infusion in the EMBARK Study
Craig M. McDonald
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.